S36ɳÁú»á

EN
S36ɳÁú»á - ÒªÍæ¾ÍÍæÉ³Áú»á S36ɳÁú»á - ÒªÍæ¾ÍÍæÉ³Áú»á
ÐÂÎÅÖÐÐÄ
2023-06-09
Ô´×ÔÆ¤·ôϸ°ûµÄÄÉÃ׿ÅÁ£¿£¿£¿ÉÖηβ¡
ÃÀ¹ú¶íº¥¶íÖÝÁ¢´óѧµÄÒ»ÏîÐÂÑо¿ÏÔʾ£¬£¬£¬£¬£¬£¬ÓɳÉÈËÆ¤·ôϸ°ûÉè¼ÆµÄÖÎÁÆÐÔÄ˽×ÔØÌå¿ÉÒÖÖÆÐ¡ÊóÊÜËð·Î²¿µÄÑ×Ö¢ºÍ×éÖ¯ËðÉË£¬£¬£¬£¬£¬£¬ÕâÒâζ×ÅÈËÃÇÓÐÍûÖÎÁÆÒòѬȾ»ò´´É˶øÑÏÖØÊÜËðµÄ·Î¡£¡£ÕâÊÇÒ»ÖÖ¾Ö²¿ÖÎÁÆ£¬£¬£¬£¬£¬£¬¿É¾­±ÇÇ»¸øÒ©²¢ÁôÔÚ·ÎÀï¡£¡£Ïà¹ØÑо¿ÔÚÏß½ÒÏþÓÚ×î½üµÄ¡¶ÏȽøÖÊÁÏ¡·ÔÓÖ¾¡£¡£
ÔĶÁ¸ü¶à
2023-06-08
Èí»¯Ã«ÄÒ¸Éϸ°ûÄÜ´Ù뱬·¢³¤
ÕýÈçÈËÃǵÄÊàŦ»áËæ×ÅÄêËêÔöÌí¶ø±äµÃ½©Ó²£¬£¬£¬£¬£¬£¬Ê¹È˻ÄÑÌâÒ»Ñù£¬£¬£¬£¬£¬£¬Ã«ÄÒ¸Éϸ°ûÒ²»á±äµÃ½©Ó²£¬£¬£¬£¬£¬£¬ÈÃÈ˸üÄѳ¤³öÃæ·¢¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬ÃÀ¹úÎ÷±±´óѧµÈ»ú¹¹¿ÆÑ§¼ÒÔÚ×îÐÂÒ»ÆÚ¡¶ÃÀ¹ú¹ú¼Ò¿ÆÑ§ÔºÔº¿¯¡·ÉϽÒÏþÂÛÎijÆ£¬£¬£¬£¬£¬£¬ËûÃÇÔÚʵÑéÊóÄ£×ÓÉÏ¿ªÕ¹µÄÒ»Ïî×îÐÂÑо¿·¢Ã÷£¬£¬£¬£¬£¬£¬Èí»¯½©Ó²µÄëÄÒ¸Éϸ°û¿ÉÔö½ø¶¯Îﳤ³öë·¢¡£¡£
ÔĶÁ¸ü¶à
2023-06-07
»îϸ°û3D´òÓ¡³ÉÈËÌå×éÖ¯
¶íÂÞ˹лÇÐŵ·òĪ˹¿ÆµÚÒ»¹úÁ¢Ò½¿Æ´óѧºÍ¶íÂÞ˹¿ÆÑ§ÔºÐ»Ãçŵ·ò»¯Ñ§ÎïÀíÖÐÐÄÏàÖú£¬£¬£¬£¬£¬£¬Ñз¢³öʹÓûîϸ°û¶ÔÈËÌå×éÖ¯¾ÙÐÐÈýάÉúÎï´òÓ¡µÄÊÖÒÕ£¬£¬£¬£¬£¬£¬Ê¹ÎªÌض¨ÈËȺ´òÓ¡Æ÷¹ÙºÍ×éÖ¯³ÉΪ¿ÉÄÜ¡£¡£ ¶í¿ÆÑ§¼ÒÒѾ­Íê³ÉÁËÒ»¸ö3DÉúÎï´òÓ¡ÖÜÆÚ£¬£¬£¬£¬£¬£¬²¢»ñµÃÁËÉúÎï×éÖ¯µÈЧÎ£¬£¬£¬£¬£¬ÕâÊÇÒ»ÖÖÈ˹¤´òÓ¡µÄÈËÌå×éÖ¯»îÌå¡£¡£
ÔĶÁ¸ü¶à
2023-06-06
¿ÆÑ§¼ÒÕ¹ÏÖhPSCÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾­²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢
Ê©Íòϸ°û£¨Schwann cells£¬£¬£¬£¬£¬£¬SC£©ÊÇÖÜΧÉñ¾­ÏµÍ³ÖÐÖ÷ÒªµÄ½ºÖÊϸ°û¡£¡£SCÓëÐí¶à¼²²¡ÓйØ£¬£¬£¬£¬£¬£¬ÌÇÄò²¡ÖÜΧÉñ¾­²¡±ä£¨Diabetic peripheral neuropathy£¬£¬£¬£¬£¬£¬DPN£©ÊÇÆäÖÐÖ®Ò»¡£¡£ÃÀ¹ú¼ÓÖÝ´óѧ¾É½ðɽ·ÖУÑо¿Ö°Ô±·¢Ã÷£¬£¬£¬£¬£¬£¬È˶àÐÑĿϸ°û£¨human pluripotent stem cell£¬£¬£¬£¬£¬£¬hPSC£©ÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾­²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢¡£¡£¸ÃÑо¿Ð§¹ûÓÚ¿ËÈÕ½ÒÏþÔÚ¡¶Cell Stem Cell¡·ÔÓÖ¾ÉÏ£¬£¬£¬£¬£¬£¬ÌâΪ£ºDeriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy¡£¡£
ÔĶÁ¸ü¶à
2023-05-29
´ÅÉùÇý¶¯µÄCAR-Tϸ°û΢ÐÍ»úеÈË¿¹°©¸ü¾«×¼
¸ÃÑо¿¿ª·¢ÁËÒ»ÖÖ»ùÓÚCAR-Tϸ°ûµÄ΢ÐÍ»úеÈË£¨M-CAR T£©£¬£¬£¬£¬£¬£¬ÓÐÍûÈÿ¹°©¸ü¾«×¼¡£¡£
ÔĶÁ¸ü¶à
2023-05-23
ÎÒ¹ú¿ÆÑ§¼ÒÑз¢ÄÉÃ×ÄÒÅÝת´ï¿¹ÌåÔöÇ¿µÄ¿¹Ö×ÁöÃâÒßÁ¦
CD47/PD-L1¿¹Ìå×éºÏÌåÏÖ³ö³¤ÆÚµÄ¿¹Ö×ÁöÃâÒßÁ¦£¬£¬£¬£¬£¬£¬µ«ÆäÒ²»áÒýÆðÃâÒßÏà¹Ø²»Á¼ÊÂÎñ£¨IRAEs£©¶øÓ°ÏìÁÙ´²ÁÆÐ§¡£¡£ÄÏ·½Ò½¿Æ´óѧµÚÒ»Á¥ÊôÒ½ÔºÑо¿ÍŶÓÑз¢¾ÛºÏÎïÄÉÃ×ÄÒÅÝ£¬£¬£¬£¬£¬£¬ÓÃÓÚµÝËÍCD47/PD-L1¿¹Ì壬£¬£¬£¬£¬£¬ÔöÇ¿ÁË·ÎÏÙ°©µÄ¿¹Ö×ÁöÃâÒßÁ¦²¢½µµÍÁËÃâÒß¶¾ÐÔ¡£¡£¸ÃÑо¿Ð§¹ûÓÚ¿ËÈÕ½ÒÏþÔÚ¡¶Advanced Science¡·ÔÓÖ¾ÉÏ£¬£¬£¬£¬£¬£¬ÌâΪ£ºMicrofluidics-enabled nano-vesicle delivers CD47/PD-L1 antibodies to enhance anti-tumor immunity and reduce immunotoxicity in lung adenocarcinoma¡£¡£
ÔĶÁ¸ü¶à
2023-05-23
¿ÆÑ§¼Ò¿ª·¢ÁËÒ»ÖÖʹÓöàÐÑĿϸ°û²¿·Ö»Ö¸´ÊÓÍøÄ¤¹¦Ð§µÄÐÂÒªÁì
ÑÛ¾¦ÖеĹâ¸ÐÊÜÆ÷ÍË»¯Êǵ¼ÖÂÊÓÁ¦Ï½µµÄÖ÷ÒªÔµ¹ÊÔ­ÓÉÖ®Ò»£¬£¬£¬£¬£¬£¬×îÖÕ¿ÉÄܵ¼ÖÂʧÃ÷£¬£¬£¬£¬£¬£¬ÏÖÔÚÉÐÎÞÓÐÓÃÖÎÁÆÒªÁì¡£¡£½üÆÚ£¬£¬£¬£¬£¬£¬¶Å¿Ë-ÐÂ¼ÓÆÂ¹úÁ¢´óѧҽѧԺÓ뿨ÂÞÁÖ˹¿¨Ñ§ÔºµÈ»ú¹¹µÄÑо¿Ö°Ô±¿ª·¢ÁËÒ»ÖÖÐÂÒªÁ죬£¬£¬£¬£¬£¬Äܹ»Ôö½øÈËÀàÅßÌ¥¸Éϸ°û£¨hESCs£©·Ö½âΪ¸Ð¹â×æÏ¸°û£¬£¬£¬£¬£¬£¬½«ÕâЩϸ°ûÒÆÖ²µ½ÊµÑéÄ£×ÓÖпÉÒÔ²¿·Ö»Ö¸´ÊÓÍøÄ¤¹¦Ð§¡£¡£Ñо¿Ð§¹û½ÒÏþÔÚ¡¶Molecular Therapy¡·ÆÚ¿¯£¬£¬£¬£¬£¬£¬ÎÊÌâΪ¡°Photoreceptor laminin drives differentiation of human pluripotent stem cells to photoreceptor progenitors that partially restore retina function¡±¡£¡£
ÔĶÁ¸ü¶à
2023-05-23
»ùÒò±à¼­Ï¸°ûÖÎÁÆ´óÊóÐÄÁ¦Ë¥½ß
¾ÝÓ¢¹ú¡¶Ð¿ÆÑ§¼Ò¡·ÔÓÖ¾ÍøÕ¾20ÈÕ±¨µÀ£¬£¬£¬£¬£¬£¬ÃÀ¹ú¿ÆÑ§¼ÒʹÓÃCRISPR±à¼­µÄÈËÀàÐÄÔàϸ°û×¢É䵽¼ÂýÐÔÐÄÁ¦Ë¥½ßµÄ´óÊóÌåÄÚ£¬£¬£¬£¬£¬£¬Ð§¹ûÅú×¢£¬£¬£¬£¬£¬£¬ÕâÒ»ÒªÁìÄÜʹ¸ü¶à´óÊó´æ»î£¬£¬£¬£¬£¬£¬²¢ÑÓÉìÆäÔ˶¯Ê±¼ä£¬£¬£¬£¬£¬£¬Ïà¹ØÊÖÒÕµÄÈËÌåÊÔÑé¿ÉÄÜÔÚ2025Äê×îÏÈ¡£¡£Ñо¿ÂÛÎÄÒѾ­Ìá½»ÉúÎïÔ¤Ó¡±¾ÍøÕ¾¡£¡£
ÔĶÁ¸ü¶à
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿